AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Image and broadcast library - AstraZeneca
View global media contacts. Your email address will only be used to provide you with services from AstraZeneca that you requested. You can opt out for email subscriptions at any time. Your personal information will not be provided to any third party without your permission. AstraZeneca - Image and Broadcast Library - Media Centre.
About Our Company - AstraZeneca
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Leadership - Our Company - AstraZeneca
Introducing AstraZeneca's Board of Directors, Senior Executives and Lead Scientists. Find information on each individual membership of the leadership team.
Pipeline - AstraZeneca
AstraZeneca’s deep pipeline of medicines focusing on their key therapeutic areas.
Results and presentations - AstraZeneca
Nov 6, 2024 · Accelerating AstraZeneca’s strategic and financial development: AstraZeneca to acquire Alexion
A timeline of our company history | AstraZeneca
Since 1913, we have continued to discover and develop innovative medicines for patients around the world. Find out more about the history of AstraZeneca.
Acquisition of Alexion completed - AstraZeneca
Jul 21, 2021 · AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.
Respiratory and Immunology - Our therapy areas - AstraZeneca
Our commitment. With five decades of experience, we are an established leader in respiratory care and a disruptor in immunology. We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases.
Investor Relations - AstraZeneca
Nov 6, 2024 · AstraZeneca Investor Day. Making Science Accessible. We're taking action to drive sustainability – for the health of people, society and the planet.
- Some results have been removed